SCHEMBL12423980

SCHEMBL12423980

Cc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)c(C)c2)ccc1-c1ccc(C(=O)c2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C8 P10632 1/20 0.55
BACE1 P56817 1/20 0.52
SRD5A2 P31213 3/20 0.51
RXRA P19793 1/20 0.49
RXRB P28702 1/20 0.49
PPARA Q07869 1/20 0.47
SLC1A3 P43003 1/20 0.47
SLC1A2 P43004 1/20 0.47
SLC1A1 P43005 1/20 0.47
CNR2 P34972 3/20 0.47
CNR1 P21554 1/20 0.47
APP P05067 1/20 0.47
HDAC2 Q92769 1/20 0.46
PTGS1 P23219 1/20 0.46
PTGS2 P35354 1/20 0.46
KDM1A O60341 1/20 0.45
PSEN1 P49768 1/20 0.45
PSEN2 P49810 1/20 0.45
APH1B Q8WW43 1/20 0.45
NCSTN Q92542 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12424200 0.99 CYP2C8 (0.53) CYP2C8BACE1SRD5A2RXRARXRB
SCHEMBL17166056 0.99 CYP2C8 (0.53) CYP2C8BACE1SRD5A2RXRARXRB
SCHEMBL12423989 0.99 CYP2C8 (0.53) CYP2C8BACE1SRD5A2RXRARXRB
SCHEMBL12424199 0.99 CYP2C8 (0.53) CYP2C8BACE1SRD5A2RXRARXRB
SCHEMBL12424201 0.99 CYP2C8 (0.53) CYP2C8BACE1SRD5A2RXRARXRB
SCHEMBL12424198 0.99 CYP2C8 (0.53) CYP2C8BACE1SRD5A2RXRARXRB
SCHEMBL13410666 0.93 CYP2C8 (0.55) CYP2C8BACE1SRD5A2RXRARXRB
SCHEMBL12424113 0.84 CNR2 (0.52) CYP2C8SRD5A2CNR2CNR1AKR1C3
SCHEMBL13445159 0.83 KIF11 (0.54) CYP2C8SRD5A2RXRARXRBPPARA
SCHEMBL13445154 0.83 KIF11 (0.54) CYP2C8SRD5A2RXRARXRBPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8449794-B2 Non-resonant two-photon absorption recording material and non-resonant two-photon absorption compound FUJIFILM CORPORATION (JP) 2013-05-28 US disclosed
US-8449794-B2 Non-resonant two-photon absorption recording material and non-resonant two-photon absorption compound FUJIFILM CORPORATION (JP) 2013-05-28 US disclosed
US-20120319059-A1 NON-RESONANT TWO-PHOTON ABSORPTION RECORDING MATERIAL AND NON-RESONANT TWO-PHOTON ABSORPTION COMPOUND FUJIFILM CORPORATION (JP) 2012-12-20 US disclosed
US-20120319059-A1 NON-RESONANT TWO-PHOTON ABSORPTION RECORDING MATERIAL AND NON-RESONANT TWO-PHOTON ABSORPTION COMPOUND FUJIFILM CORPORATION (JP) 2012-12-20 US disclosed
WO-2011102545-A1 NON-RESONANT TWO-PHOTON ABSORPTION RECORDING MATERIAL AND NON-RESONANT TWO-PHOTON ABSORPTION COMPOUND FUJIFILM CORPORATION (JP) 2011-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120319059-A1 NON-RESONANT TWO-PHOTON ABSORPTION RECORDING MATERIAL AND NON-RESONANT TWO-PHOTON ABSORPTION COMPOUND CRY2, KCNJ2, NONO CYP2C8 3317/4885BACE1 278/4885SRD5A2 3202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.